Internal Medicine, Endocrinology, Diabetes, & Metabolism · Houston, TX
NPI
1831279272
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
6550 Fannin St, Suite 1101
Houston, TX, 77030
Phone (713) 441-0006
Groups this clinician bills Medicare through
Medicare paid, 2024
$1,569
20 services
Medicare patients, 2024
14
Average age 62
Drug cost, 2024
$170K
811 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Morali Sharma prescribed most often to Medicare patients was Methimazole, with 211 prescriptions and refills. In total Morali Sharma wrote 811 Medicare prescriptions that cost $170K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-16.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Methimazole Generic | 211 | 679 | 84 | $4,139 |
| Levothyroxine Sodium Generic | 160 | 499 | 58 | $2,868 |
| Forteo Teriparatide | 70 | 70 | 12 | $94K |
| Hydrocortisone Generic | 52 | 153 | 20 | $3,558 |
| Cinacalcet Hcl Generic | 33 | 86 | 12 | $1,058 |
| Ultra-Fine Nano Pen Needle Pen Needle, Diabetic | 28 | 91 | 13 | $660 |
| Liothyronine Sodium Generic | 22 | 69 | Under 11 | $1,063 |
| Alendronate Sodium Generic | 19 | 53 | Under 11 | $186 |
| Calcitriol Generic | 17 | 57 | Under 11 | $912 |
| Cabergoline Generic | 17 | 48 | Under 11 | $397 |
| Testosterone Generic | 16 | 31 | Under 11 | $1,529 |
| Testosterone Cypionate Generic | 14 | 36 | Under 11 | $930 |
| Dexamethasone Generic | 13 | 13 | 11 | $71.38 |
| Fludrocortisone Acetate Generic | 12 | 39 | Under 11 | $561 |
| Risedronate Sodium Generic | 11 | 17 | Under 11 | $553 |
Brand drugs: 135 claims; generic drugs: 622 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Morali Sharma were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.